Hope Biosciences Stem Cell Research Foundation

Sugar Land, Texas 77478

0 studies enrolling now · 17 studies all time

What they study most

COVID-19, Cerebral Palsy, Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Pain, Congenital Muscular Dystrophy Due to Lamin A/C Mutation, Knee Pain Chronic, Multiple Sclerosis, Osteo Arthritis Knee, Parkinson Disease, Polyneuropathies, Post COVID-19 Syndrome, Primary Lateral Sclerosis, Adult, 1

Studies at this site

• Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD) — Completed
• Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate) — Completed
• Individual Patient Expanded Access IND to Treat Polyneuropathy — NO_LONGER_AVAILABLE
• Individual Patient Expanded Access IND of Autologous HB-adMSCS for the Treatment of Bilateral Knee Pain. — NO_LONGER_AVAILABLE
• Individual Patient Expanded Access IND of HB-adMSCs for Chronic Musculoskeletal Pain. — NO_LONGER_AVAILABLE
• Intermediate Size Patient Population Expanded Access IND for the Treatment of Patients With Parkinson's Disease. — NO_LONGER_AVAILABLE
• Intermediate Size Expanded Access Protocol for the Treatment of Post-COVID-19 Syndrome — NO_LONGER_AVAILABLE
• "Individual Patient Expanded Access IND to Treat Primary Lateral Sclerosis" — NO_LONGER_AVAILABLE
• An Expanded Access IND for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) — NO_LONGER_AVAILABLE
• Individual Patient Expanded Access IND of Autologous HB-adMSCs for the Treatment of Systemic Lupus Erythematosus (SLE) — NO_LONGER_AVAILABLE
• Individual Patient Expanded Access IND for the Treatment of Stroke — NO_LONGER_AVAILABLE
• HBCMD01- Expanded Access for the Treatment of Congenital Muscular Dystrophy. — NO_LONGER_AVAILABLE
• Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Spinal Cord Injury — NO_LONGER_AVAILABLE
• Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for the Treatment of Cerebral Palsy — NO_LONGER_AVAILABLE
• A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs Against COVID-19. — Completed
• Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis — Completed
• A Clinical Trial to Determine the Safety and Efficacy of HB-adMSCs to Provide Protection Against COVID-19 — Completed